Search

everythinglearnresearchcommunity

for

Search:↓

The protein p21 is more abundant in normal skin cells than in melanoma cells and may help protect against melanoma, with UVB light affecting its levels.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Cardiomyocyte-derived media can inhibit lung cancer cell growth and movement.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

A deletion in the CDH3 gene causes a rare disorder with short hair and vision loss.

cGVHD often severely affects the skin, causing rapid aging and other issues.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

ABCG2 protein marks stem-like skin cells in human epidermis.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

5-ARI therapy may help prevent prostate cancer progression.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Skin aging and cancer development are influenced by the competition between stem cells.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

CCL 27 levels are similar in people with and without alopecia areata.

Lgr5+ stem cells do not cause skin tumors.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.